Texas joins the ranks of states that have banned hemp-derived delta 8 THC. Its Department of State Health Services quietly placed D8 onto the state’s list of controlled substances following the legislature’s inability to pass a bill that would have banned it.
Continue reading “Whoa partner! A State Agency Quietly Banned Delta-8 in the Lone Star State”…
The post Whoa partner! A State Agency Quietly Banned Delta-8 in the Lone Star State first appeared on Kight on Cannabis.
On October 4, the South Carolina Attorney General (AG) issued an unfavorable opinion regarding the legal status of delta-8 THC at the request of the South Carolina Law Enforcement Division (SLED). In this post we discuss the AG’s flawed analysis and its likely effect.
Continue reading “The Fate of D8 in the Palmetto State: South Carolina AG Addresses Delta 8 THC”…
The post The Fate of D8 in the Palmetto State: South Carolina AG Addresses Delta 8 THC first appeared on Kight on Cannabis.
Rod discusses delta-8 THC, federal legalization, and the future of CBD on the C3 Higher Learning LV podcast with Curt Robbins and Dena Putnam.
Continue reading “Rod Discusses D8, Federal Legalization, and the Future of CBD on the C3 Podcast (Video)”…
The post Rod Discusses D8, Federal Legalization, and the Future of CBD on the C3 Podcast (Video) first appeared on Kight on Cannabis.
Notably, the “manufacture or sale of inhalable products is prohibited” under AB-45; however, the “manufacture or inhalable products for the sole purpose of sale in other states is not prohibited.” This prohibition may end up derailing AB-45 altogether.
Continue reading “California’s New Hemp CBD Bill- Boon or Bane for the State’s Hemp Industry?”…
The post California’s New Hemp CBD Bill- Boon or Bane for the State’s Hemp Industry? first appeared on Kight on Cannabis.
Are Precision Fermented Cannabinoids (PFC) an Existential Threat to the Cannabis Industry?…
Continue reading “Are Precision Fermented Cannabinoids an Existential Threat to the Cannabis Industry? (Podcast)”…
The post Are Precision Fermented Cannabinoids an Existential Threat to the Cannabis Industry? (Podcast) first appeared on Kight on Cannabis.
A group of leading hemp organizations, companies, and advocates sent a letter to Senators Schumer, Booker, and Wyden today requesting important changes to provisions of the “Cannabis Administration and Opportunity Act” (CAOA) regarding hemp and cannabidiol (CBD). You can read their letter in this blog post.
Continue reading “Hemp Leaders Comment on the “Cannabis Administration and Opportunity Act””…
The post Hemp Leaders Comment on the “Cannabis Administration and Opportunity Act” first appeared on Kight on Cannabis.
“When Vapor Voice published an article on Delta-8 THC and other minor THC products in its last issue it seems readers had more questions concerning newly marketed cannabinoids than the story answered. To gain more insight into the state of the current overall global cannabis market, we went to one of the best resources in the business.”
Continue reading “Rod Discusses Delta 8 THC and International Cannabis Markets with Vapor Voice”…
The post Rod Discusses Delta 8 THC and International Cannabis Markets with Vapor Voice first appeared on Kight on Cannabis.
The North Carolina General Assembly (NCGA) has officially missed an opportunity to…
Continue reading “North Carolina Hemp Program to be Regulated by the Feds”…
The post North Carolina Hemp Program to be Regulated by the Feds first appeared on Kight on Cannabis.
Rod Discusses Cannabis Banking, Taxation, Federal Legalization, and Mexico With CannaBiz Connect (Video)
I recently discussed cannabis banking, taxation, federal legalization, and cannabis legalization in Mexico with Earl Carruthers of CannaBiz Connect. You can watch the of our conversation video here.
Continue reading “Rod Discusses Cannabis Banking, Taxation, Federal Legalization, and Mexico With CannaBiz Connect (Video)”…
The post Rod Discusses Cannabis Banking, Taxation, Federal Legalization, and Mexico With CannaBiz Connect (Video) first appeared on Kight on Cannabis.
The HIA issued a statement in support of delta 8 THC and other hemp cannabinoids.The Hemp Industries Association (HIA) issued a press release and accompanying legal position statement in support of delta-8 THC and other hemp cannabinoids today. We are proud to represent the HIA and to have prepared the position statement. The HIA has a long history of supporting hemp and participants in the hemp industry, including by filing a series of lawsuits against the Drug Enforcement Administration (DEA). At a time when a number of law enforcement agencies, state departments of agriculture, and even other hemp organizations are taking public stances against delta-8 THC, it is refreshing that the HIA is willing to step up and publicly support the whole plant. You can read the legal position statement below or by clicking here. You can read the HIA’s press release by clicking here.June 23, 2021ATTORNEY ROD KIGHT REPRESENTS HEMP BUSINESSES THROUGHOUT THE WORLD.Rod Kight is an international hemp lawyer. He represents businesses throughout the hemp industry. Additionally, Rod speaks at hemp and cannabis conferences, drafts and presents legislation to foreign governments, is regularly quoted on hemp and cannabis matters in the media, and is the editor of the Kight on Cannabis legal blog, which discusses legal issues affecting the hemp and cannabis industry. You can contact him by clicking here.
Marijuana impairs a driver’s reaction time, decision-making ability, capacity to accurately track objects, balance and equilibrium. Still, it is difficult to measure when a person is impaired. The intoxicating ingredient in cannabis, tetrahydrocannabinol (THC), is metabolized differently by individuals and remains in the body long after its psychoactive effects have ceased. Currently, there is no way to reliably measure whether a person who has ingested cannabis an hour earlier is impaired because THC concentration does not correlate well with subjective impairment.
The Pennsylvania Department of Health (DOH) reported that almost $100 million in medical marijuana sales occurred between February 15, 2018, and February 15, 2019, the first full year that medical cannabis was available to Pennsylvania patients. More than $40 million in sales occurred between growers and dispensaries. Pennsylvania does not tax sales to patients, but does tax transactions between growers and dispensaries at a rate of 5%. Thus, in the first year of licensed sales, the Commonwealth received approximately $2 million in tax revenue from medical cannabis.
The 2018 U.S. Farm Bill has opened the gates to industrial hemp farming. Hemp, a crop that has been banned in the United States since 1937, now may be legally grown. While the most popular product of hemp − oils containing cannabidiol (CBD) and other naturally occurring non-psychoactive cannabinoids − are still subject to conflicting federal and state regulations, the plant itself may be grown across the United States.
The Commonwealth of Pennsylvania wants medical researchers to study cannabis at Pennsylvania medical schools, eight of which have been certified as Academic Clinical Research Centers (ACRCs). ACRCs can contract with Clinical Registrants (CRs), entities that the Commonwealth will license to cultivate, package and dispense cannabis for medical research. An entire set of regulations, commonly referred to as “Chapter 20,” has been drafted, redrafted and amended to make medical research of cannabis a reality in the Commonwealth.
On December 18, 2018, the Pennsylvania Department of Health (DOH) issued 23 cannabis dispensary permits (Phase II licenses). Fifty entities have been awarded dispensary licenses, which is the total number allowed under Pennsylvania’s Medical Marijuana Act. Each licensee can operate up to three dispensaries, bringing the total number of possible dispensaries in Pennsylvania to 150.
As the legal status of cannabis evolves, state legislatures are confronted with a difficult moral issue – how should local and state governments treat persons convicted of offenses that are no longer illegal? Below is a discussion of some of the options.
But of course, the “hemp oil” or cannabidiol (CBD) remains illegal under state law. Even if the CBD is locally sourced and sold through a licensed dispensary, edibles are not legal in Pennsylvania. Edibles are presently restricted to underage patients New Jersey. Moreover, Pennsylvania’s Medical Marijuana Act (MMA) strictly prohibits advertising or packaging that appeal to children. Candy-shaped CBD probably runs afoul of the spirit of the MMA.
National legalization of cannabis is now a reality − in Canada and Uruguay. Further south, we are still waiting, our hopes stoked by committed legislators who assure us that changes are coming soon.
The Pennsylvania Commonwealth Court has decided a new case that may have a huge impact on cannabis licensing in the Mid-Atlantic region. The Commonwealth Court hears cases involving state and local government entities and state agencies in Pennsylvania and has heard a number of challenges regarding the administration of the 2016 Medical Marijuana Act (MMA).
On September 21, 2018, the Commonwealth of Pennsylvania certified eight medical schools as Academic Clinical Research Centers (ACRCs). The following schools are now certified by the Commonwealth of Pennsylvania to contract with Clinical Registrants (CRs) to conduct medical research: